Cinnamon review reports changes in metabolic markers
An umbrella review found favorable glucose and lipid results in people with metabolic diseases, but the abstract does not quantify the changes.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review reports favorable findings for fasting blood glucose and blood lipids, particularly in diabetes and metabolic syndrome. It also describes possible changes in insulin resistance, antioxidant capacity and blood pressure. These are metabolic measurements; the abstract does not establish fewer complications, better quality of life or benefits for people without metabolic disease.
The abstract supplies no pooled effect sizes, confidence intervals, quality-assessment results or adverse-event findings. The size, certainty and safety of the reported changes remain unclear.
A review of reviews
An umbrella review brings together existing meta-analyses rather than enrolling a new group of participants. Here, the authors summarized randomized placebo-controlled trials through those reviews and assessed the reviews' methodological quality.
Subgroups do not settle dosing
Subgroup patterns involved supplement dose and intervention length, but the abstract provides no effect estimates for those comparisons. They therefore cannot establish a preferred dose or show that a shorter course works better.
The original publication
The effects of cinnamon on patients with metabolic diseases: an umbrella review of meta-analyses of randomized controlled trials.
Gou H, Zhong L, Wei Q et al.
Front Nutr · 2025
- PubMed ID
- 41256917
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.